Xu Chen, Yuan Lutao, Tian Hengli, Cao Heli, Chen Shiwen
Department of Neurosurgery, Sixth Affiliated Hospital, Shanghai Jiaotong University, Shanghai, 200233, China,
Tumour Biol. 2013 Dec;34(6):3457-64. doi: 10.1007/s13277-013-0922-9. Epub 2013 Jul 12.
Methylenetetrahydrofolate reductase (MTHFR) gene plays key roles not only in folate metabolism but also in carcinogenesis. The single nucleotide polymorphism MTHFR C677T has been indicated in the development of various tumors. The effect of the MTHFR C677T polymorphism on brain tumors remains poorly understood. We performed the present meta-analysis and aimed to provide a better understanding of the pathogenesis of brain tumors. A literature search of the PubMed, Embase, Web of Science, and Wanfang databases was carried out for potential relevant publications. We calculated the pooled odds ratio (OR) with corresponding 95% confidence interval (95% CI) to assess the association of MTHFR C677T with the susceptibility to brain tumors. We also performed stratified analysis and sensitivity analysis to further estimate the genetic association. All statistical analyses were conducted by the use of STATA 11.0 (STATA Corporation, College Station, TX, USA). Eight case-control studies involving a total of 3,059 cases and 3,324 controls were retrieved according to the inclusion criteria. The overall ORs suggested that the MTHFR C677T variant can exert a risk effect on brain tumor development under the following contrast models (OR(TC vs. CC) = 1.14, 95% CI 1.02-1.27, P OR = 0.018; OR(TT + TC vs. CC)= 1.23, 95% CI 1.01-1.51, P(OR) = 0.043). No significant correlation was identified among the Caucasians, but not among the Asians. In addition, the TC genotype carriers were more susceptible to meningioma when compared with the CC genotype carriers (OR(TC vs. CC) = 1.38, 95% CI 1.15-1.65, P(OR) < 0.001). The MTHFR C677T polymorphism seemed to exert no effect on glioma risk. The current meta-analysis firstly provides evidence that the MTHFR C677T polymorphism may modify the risk for brain tumors, particularly meningioma. The role of the MTHFR C677T variant in brain tumor pathogenesis across diverse ethnicities needs further elucidation by more future studies with large sample size.
亚甲基四氢叶酸还原酶(MTHFR)基因不仅在叶酸代谢中起关键作用,还在肿瘤发生过程中发挥重要作用。单核苷酸多态性MTHFR C677T已被证实与多种肿瘤的发生发展有关。然而,MTHFR C677T多态性对脑肿瘤的影响仍知之甚少。我们进行了本次荟萃分析,旨在更好地理解脑肿瘤的发病机制。通过检索PubMed、Embase、Web of Science和万方数据库,查找潜在的相关出版物。我们计算了合并比值比(OR)及相应的95%置信区间(95%CI),以评估MTHFR C677T与脑肿瘤易感性之间的关联。我们还进行了分层分析和敏感性分析,以进一步评估基因关联性。所有统计分析均使用STATA 11.0软件(美国德克萨斯州大学站市STATA公司)完成。根据纳入标准,共检索到8项病例对照研究,涉及3059例病例和3324例对照。总体OR值表明,在以下对比模型中,MTHFR C677T变异可能对脑肿瘤的发生发展产生风险效应(OR(TC vs. CC)= 1.14,95%CI 1.02 - 1.27,P(OR) = 0.018;OR(TT + TC vs. CC)= 1.23,95%CI 1.01 - 1.51,P(OR) = 0.043)。在白种人中未发现显著相关性,但在亚洲人中存在显著相关性。此外,与CC基因型携带者相比,TC基因型携带者患脑膜瘤的易感性更高(OR(TC vs. CC)= 1.38,95%CI 1.15 - 1.65,P(OR) < 0.001)。MTHFR C677T多态性似乎对胶质瘤风险没有影响。本次荟萃分析首次提供了证据,表明MTHFR C677T多态性可能改变脑肿瘤尤其是脑膜瘤的发病风险。MTHFR C677T变异在不同种族脑肿瘤发病机制中的作用,需要更多大样本的后续研究进一步阐明。